Product Overview
CagriSema is a combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a GLP-1 receptor agonist, under clinical investigation for metabolic conditions. This product listing covers two powder presentations, 5+5 mg and 10+10 mg, supplied in 10-vial kits.
Technical Specifications
|
Parameter |
Specification |
|
Product Name |
CagriSema Compound |
|
Listed Strengths |
5+5 mg / 10+10 mg |
|
Product Form |
Powder |
|
Pack Size |
10 vials |
|
Active Ingredients |
Cagrilintide and semaglutide |
Product Effects
Weight Management: CagriSema is being investigated for weight management, combining cagrilintide and semaglutide through complementary receptor pathways.
Blood Glucose Control: Clinical trials have evaluated its effects on HbA1c, with Phase II results showing greater improvement than cagrilintide alone.
Clinical Weight-Loss Results: A Phase II trial reported an average body-weight reduction of 15.6% after 32 weeks.
Clinical Development: CagriSema entered Phase III clinical trials in 2023 and remains investigational.
Composition and Strength
Dual-Component Composition
CagriSema combines cagrilintide, a long-acting amylin analogue, and semaglutide, a GLP-1 receptor agonist. The two components are listed together as a dual-component formulation.
Strength Notation
The available presentations are labeled 5+5 mg and 10+10 mg. Each strength notation represents the stated amounts of the two components. The product label and batch-specific specification identify the applicable quantity basis for each presentation.
Quality Documentation
Certificate of Analysis (CoA)
Each available batch-specific CoA identifies the product batch, analytical test items, test results and applicable specifications.
Product Specifications
Product specifications document the stated composition, labeled strength, physical form and packaging information for the listed product.
Analytical Test Reports
Available analytical reports present the test methods, measured results and corresponding laboratory information for the tests performed.
Batch Traceability
Product batch identifiers link the corresponding labels and quality documentation, supporting batch-level record verification.
Packaging and Product Identification
Pack Configuration
Each kit is listed as a 10-vial presentation. The supplied package should contain the specified number of vials corresponding to the ordered product and strength.
Vial Identification
Product labels identify the product name, strength notation and batch number, providing the basic information needed to distinguish different product presentations and batches.
Receiving Inspection
Upon receipt, check the vial count, label consistency, packaging integrity and batch identification against the order details and accompanying product documents.
Storage Conditions
Storage Temperature: Store lyophilized powder at −20°C.
Light and Moisture Protection: Keep the product sealed and protected from light and moisture.
Shelf Life: Refer to the expiry date and batch-specific stability documentation for the applicable shelf life.
Supply Information
Minimum Order Quantity (MOQ): 1 kit, with 10 vials per kit.
Lead Time: 6–10 business days, subject to confirmed order and applicable regulatory requirements.
Quality Documentation: Available documentation may include product specifications, batch-specific Certificate of Analysis (CoA), and analytical test reports, depending on the product and batch.
Payment Terms: Payment terms are confirmed in the formal quotation before any transaction.
Shipping Information: Shipping costs and estimated transit times depend on the destination, shipping method, and applicable import requirements.
Supplier Verification: Company registration details and the supplier's role as manufacturer or distributor are available for business verification where applicable.
Ordering Process
Product and Order Confirmation
Confirm the selected CagriSema presentation, 5+5 mg or 10+10 mg, the required quantity and destination.
Quotation and Payment
A formal quotation specifies the ordered products, quantities, unit prices, total amount, payment terms and applicable shipping charges.
Order Processing
Order processing begins after the order details and payment arrangements are confirmed. The estimated lead time is 6–10 business days, as stated in the supply terms.
Shipment Arrangement
Shipping arrangements are coordinated according to the destination, applicable import requirements and agreed shipping method. Required commercial and shipping documents are prepared for the order.
Delivery and Order Follow-up
Available shipment tracking information is provided where supported by the shipping method. Order references are retained to support delivery inquiries and post-shipment communication.
Customer Feedback






Our Factory


Delivery And Transportation


FAQ
Hot Tags: cagrisema 5+5mg 10+10mg compound 10 vials powder, China cagrisema 5+5mg 10+10mg compound 10 vials powder suppliers, factory, Cagrisema 5mg 5mg, Cagritirze 5 5mg, Cagritirze peptide, Mazdutide dosage, Retatrutide Cost 5mg 10mg 15mg 30mg 10 Vials, tirzepatide online




